The Company will focus resources on advancing its lead asset, PYX-201- PYX-201 is a novel first-in-concept antibody-drug conjugate (ADC) where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback